CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended |
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 |
Cash flows from operating activities: | | | | |
Net Loss | $ (3,356) | $ (20,732) | $ (5,866) | $ (32,094) |
Adjustments to reconcile net income to net cash provided by (used in) operating activities: | | | | |
Depreciation | 1,156 | 1,327 | 2,371 | 2,647 |
Stock-based compensation | 2,187 | 2,425 | 3,547 | 5,893 |
Amortization of intangible assets | 153 | 277 | 305 | 553 |
Increase (Decrease) in accrued severance pay, net | (107) | 13 | (165) | 73 |
Decrease in other assets, other receivables and prepaid expenses | 955 | 468 | 1,672 | 967 |
Increase in accrued interest and amortization of premium/discount on marketable securities | (405) | (166) | (777) | (147) |
Decrease in operating leases liability | (159) | (438) | (618) | (1,543) |
Decrease in operating lease right-of-use asset | 622 | 728 | 1,174 | 1,450 |
Decrease (Increase) in trade receivables | (2,789) | 10,403 | (2,980) | 14,889 |
Decrease (Increase) in inventories | 2,101 | (1,645) | 2,268 | (5,098) |
Increase (Decrease) in trade payables | 278 | (2,941) | 16 | (2,202) |
Decrease in employees and payroll accruals | (649) | (1,042) | (4,135) | (2,494) |
Increase (Decrease) in deferred revenues | 595 | 870 | 1,965 | (1,299) |
Increase (Decrease) in other payables, accrued expenses and other long term liabilities | 542 | (923) | (12) | (1,824) |
Amortization of issuance costs of Convertible debt | 50 | 49 | 100 | 98 |
Net cash provided by (used in) operating activities | 1,174 | (11,327) | (1,135) | (20,131) |
Cash flows from investing activities: | | | | |
Decrease (Increase) in restricted deposit | (1) | (224) | 703 | (224) |
Investment in short-term bank deposits | (3,800) | 0 | (3,800) | (15,900) |
Withdrawal of short-term bank deposits | 0 | 21,700 | 10,000 | 54,600 |
Purchase of property and equipment | (957) | (290) | (1,386) | (560) |
Investment in marketable securities | (10,477) | (9,584) | (34,752) | (18,567) |
Proceeds from redemption or sale of marketable securities | 7,225 | 590 | 32,060 | 3,960 |
Net cash provided by (used in) investing activities | (8,010) | 12,192 | 2,825 | 23,309 |
Cash flows from financing activities: | | | | |
Proceeds from exercise of stock options | 1 | 0 | 1 | 0 |
Net cash provided by financing activities | 1 | 0 | 1 | 0 |
Increase (Decrease) in cash and cash equivalents | (6,835) | 865 | 1,691 | 3,178 |
Cash and cash equivalents at the beginning of the period | 22,718 | 14,608 | 14,192 | 12,295 |
Cash and cash equivalents at the end of the period | $ 15,883 | $ 15,473 | $ 15,883 | $ 15,473 |